TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
PRTA

Prothena Corporation plc

Healthcare · Biotechnology

8.70$ -3.4% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Prothena Corporation plc (PRTA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 327 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PRTA
Line item 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
3.3 3.6 129 182 304 385 460 496 499 419 333 609 758 696 547 327
0.1 126 178 299 377 391 426 431 378 299 585 719 639 485 315
125 177 294 371 387 418 428 376 295 579 710 619 471 308
125 177 294 371 387 418 428 376 295 579 710 619 471 308
0.2 0.1 1.8 0.5 0.2 0.2 0.0 0.1 0.0 0.0 0.1 5.2 0.0
-0.2 -0.1 -1.8 -0.5 -0.2 -0.2 0.0 -0.1 1.4 0.0 -0.1 -5.2
2.4 2.5 3.4 3.4 3.1 3.9 56 55 53 3.9 2.6 2.0 8.0
0.0 0.0 0.0 0.0 0.0
0.1 0.0 0.0 0.0 0.0 0.0 0.0
3.2 10 2.8 9.1 14 25 95 89 176 146 149 143 136 135 60 46
1.8 8.4 1.7 7.4 12 22 41 37 15 18 26 33 50 57 49 41
51 51 51 51 0.7 1.6 5.1 5.5 5.9 6.5 1.1 2.6 2.9
0.1 0.4 1.8 4.7 4.5 13 14 1.5 1.2 4.1 3.7 9.3 25 7.8 5.9
0.0 0.0 0.0 39 36
0.1 -6.4 126 173 290 361 365 407 323 273 184 466 622 561 487 280
-13 -0.3 -41 -48 -129 -289 -442 -598 -672 -783 -716 -833 -980 -1,102 -1,346
14 18 18 15 19 25 30 34 38 40 40 40 48 47 53 54 54

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?